TY - JOUR
T1 - Cardiac responses to β-adrenoceptor stimulation is partly dependent on mitochondrial calcium uniporter activity
AU - Fernández-Sada, E.
AU - Silva-Platas, C.
AU - Villegas, C. A.
AU - Rivero, S. L.
AU - Willis, B. C.
AU - García, N.
AU - Garza, J. R.
AU - Oropeza-Almazán, Y.
AU - Valverde, C. A.
AU - Mazzocchi, G.
AU - Zazueta, C.
AU - Torre-Amione, G.
AU - García-Rivas, G.
PY - 2014
Y1 - 2014
N2 - Background and Purpose Despite the importance of mitochondrial Ca 2+ to metabolic regulation and cell physiology, little is known about the mechanisms that regulate Ca2+ entry into the mitochondria. Accordingly, we established a system to determine the role of the mitochondrial Ca2+ uniporter in an isolated heart model, at baseline and during increased workload following β-adrenoceptor stimulation. Experimental Approach Cardiac contractility, oxygen consumption and intracellular Ca 2+ transients were measured in ex vivo perfused murine hearts. Ru360 and spermine were used to modify mitochondrial Ca2+ uniporter activity. Changes in mitochondrial Ca2+ content and energetic phosphate metabolite levels were determined. Key Results The addition of Ru360, a selective inhibitor of the mitochondrial Ca2+ uniporter, induced progressively and sustained negative inotropic effects that were dose-dependent with an EC50 of 7 μM. Treatment with spermine, a uniporter agonist, showed a positive inotropic effect that was blocked by Ru360. Inotropic stimulation with isoprenaline elevated oxygen consumption (2.7-fold), Ca2+-dependent activation of pyruvate dehydrogenase (5-fold) and mitochondrial Ca2+ content (2.5-fold). However, in Ru360-treated hearts, this parameter was attenuated. In addition, β-adrenoceptor stimulation in the presence of Ru360 did not affect intracellular Ca2+ handling, PKA or Ca2+/calmodulin-dependent PK signalling. Conclusions and Implications Inhibition of the mitochondrial Ca2+ uniporter decreases β-adrenoceptor response, uncoupling between workload and production of energetic metabolites. Our results support the hypothesis that the coupling of workload and energy supply is partly dependent on mitochondrial Ca2+ uniporter activity.
AB - Background and Purpose Despite the importance of mitochondrial Ca 2+ to metabolic regulation and cell physiology, little is known about the mechanisms that regulate Ca2+ entry into the mitochondria. Accordingly, we established a system to determine the role of the mitochondrial Ca2+ uniporter in an isolated heart model, at baseline and during increased workload following β-adrenoceptor stimulation. Experimental Approach Cardiac contractility, oxygen consumption and intracellular Ca 2+ transients were measured in ex vivo perfused murine hearts. Ru360 and spermine were used to modify mitochondrial Ca2+ uniporter activity. Changes in mitochondrial Ca2+ content and energetic phosphate metabolite levels were determined. Key Results The addition of Ru360, a selective inhibitor of the mitochondrial Ca2+ uniporter, induced progressively and sustained negative inotropic effects that were dose-dependent with an EC50 of 7 μM. Treatment with spermine, a uniporter agonist, showed a positive inotropic effect that was blocked by Ru360. Inotropic stimulation with isoprenaline elevated oxygen consumption (2.7-fold), Ca2+-dependent activation of pyruvate dehydrogenase (5-fold) and mitochondrial Ca2+ content (2.5-fold). However, in Ru360-treated hearts, this parameter was attenuated. In addition, β-adrenoceptor stimulation in the presence of Ru360 did not affect intracellular Ca2+ handling, PKA or Ca2+/calmodulin-dependent PK signalling. Conclusions and Implications Inhibition of the mitochondrial Ca2+ uniporter decreases β-adrenoceptor response, uncoupling between workload and production of energetic metabolites. Our results support the hypothesis that the coupling of workload and energy supply is partly dependent on mitochondrial Ca2+ uniporter activity.
UR - http://www.scopus.com/inward/record.url?scp=84906837058&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84906837058&partnerID=8YFLogxK
U2 - 10.1111/bph.12684
DO - 10.1111/bph.12684
M3 - Article
C2 - 24628066
AN - SCOPUS:84906837058
SN - 0007-1188
VL - 171
SP - 4207
EP - 4221
JO - British Journal of Pharmacology
JF - British Journal of Pharmacology
IS - 18
ER -